Bohen Sean has filed 14 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 275000 shares of Olema Pharmaceuticals, Inc. ($OLMA) on February 02, 2026.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | A | Performance Stock Options (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 85,732,221 | 9999.99% | 0.32% |
| Feb. 2, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 850000 | $0.00 | 850,000.0000 | 85,732,221 | 9999.99% | 0.99% |
| Dec. 26, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | President and CEO | G | Common Stock | 8500 | $0.00 | 237,650.0000 | 85,732,221 | 3.45% | 0.01% |
| Feb. 28, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 58,743,522 | 9999.99% | 1.11% |
| Dec. 11, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | S | Common Stock | 1267 | $9.39 | 241,662.0000 | 57,262,803 | 0.52% | 0.00% |
| Dec. 11, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | S | Common Stock | 55907 | $8.66 | 242,929.0000 | 57,262,803 | 18.71% | 0.10% |
| Dec. 10, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | S | Common Stock | 52328 | $9.37 | 298,836.0000 | 57,262,803 | 14.90% | 0.09% |
| Dec. 9, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | A | Common Stock | 204750 | $0.00 | 351,164.0000 | 57,262,803 | 139.84% | 0.36% |
| Feb. 1, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 621500 | $0.00 | 621,500.0000 | 45,247,098 | 9999.99% | 1.37% |
| Nov. 21, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | S | Common Stock | 2602 | $15.29 | 172,857.0000 | 0 | 1.48% | 0.00% |
| Nov. 22, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | S | Common Stock | 27932 | $13.90 | 144,925.0000 | 0 | 16.16% | 0.00% |
| Nov. 20, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | A | Common Stock | 110250 | $0.00 | 202,150.0000 | 0 | 119.97% | 0.00% |
| Nov. 21, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | PRESIDENT AND CEO | S | Common Stock | 26691 | $14.84 | 175,459.0000 | 0 | 13.20% | 0.00% |
| Feb. 1, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Bohen Sean | President and CEO | A | Stock Option (Right to Buy) | 550000 | $0.00 | 550,000.0000 | 0 | 9999.99% | 0.00% |